Bioidentical hormones for menopause: what they are, contraindications and how they differ from HRT
“They’re natural, so they’re safer.”
“They’re different from hormone therapy.”
“A saliva test is all it takes to find the perfect dose.”
If you’ve been looking for information on bioidentical hormones for menopause, you’ve probably come across at least one of these claims. And you may have wondered who to believe.
Let’s start with the most important point: bioidentical hormones are not an alternative to hormone replacement therapy (HRT). Many medicines used for menopause already contain bioidentical hormones such as estradiol and micronized progesterone.
The word “bioidentical” describes the structure of the molecule, not a guarantee of effectiveness or safety. And “compounded” describes how a medicine is prepared, not whether it is good or bad. In this article we try to bring some clarity, starting from the questions women ask us most often: what bioidentical hormones are and which ones exist, what they are used for and who they are suitable for, whether they have contraindications and how they differ from HRT.
In short: what to remember about bioidentical hormones for menopause
- Bioidentical means the molecule has the same structure as a hormone produced by the human body; it does not mean “risk-free”.
- Estradiol and micronized progesterone are bioidentical hormones that are also found in licensed medicines.
- Compounded preparations are legitimate pharmaceutical preparations governed by specific rules; for personalized hormone blends, however, there are often no clinical studies comparable to those for licensed medicines.
- There is no saliva test that can identify the “perfect dose” of HRT for every woman.
- Testosterone also plays a role in women’s health, but the evidence supports its therapeutic use only in well-defined conditions.
What are bioidentical hormones?
Bioidentical hormones are molecules made in the laboratory with the same chemical structure as the hormones produced by the human body. They are often made from plant precursors, such as soy or yam, which are chemically transformed. So “plant-derived”, a label often found on these products, does not mean the final product is a natural cream or a supplement: it is an active hormone, with effects and possible contraindications.
There is also something that surprises many women: bioidentical hormones are neither new nor a niche. Many medicines for hormone replacement therapy, prescribed for years and fully licensed, contain precisely bioidentical hormones, such as estradiol and micronized progesterone. In the United Kingdom, the national health service uses the expression “body identical” for these products, meaning identical to those of the body, to distinguish them from the personalized preparations made up in pharmacies, the so-called compounded bioidentical hormones, which we discuss further on.
Bioidentical, therefore, does not automatically mean safer or more effective. The main independent reviews, including the 2020 report by the National Academies and the 2023 ACOG Clinical Consensus, conclude that there is no evidence to support the claims of greater safety and effectiveness attributed to personalized (compounded) bioidentical hormone preparations. What makes the difference is the molecule, the dose, the route of administration and, above all, the medical history of the person taking them.
Why are bioidentical hormones called that?
“Bioidentical” combines “bio”, which refers to what is biological, produced by the body, and “identical”. It therefore describes a hormone that has the same chemical structure as the one the body produces on its own. A bioidentical hormone does not “imitate” the natural hormone, nor does it merely resemble it: at the molecular level, it is the same substance.
It is worth knowing, however, that “bioidentical” is not a scientific or regulatory category, but a term used mainly in everyday language and in marketing. This is why scientific societies prefer to name the molecule directly, such as estradiol or micronized progesterone, and in the United Kingdom the national health service uses the expression “body identical” for licensed medicines. The aim is to prevent the word from being automatically associated with the idea of something more natural or safer.
Bioidentical hormones and bioequivalent hormones: are they the same thing?
If you have searched for information online, you may also have come across the expression “bioequivalent hormones”. In searches and in everyday language it is often used as a synonym for bioidentical hormones, and people who use it usually mean exactly that: hormones with the same structure as those produced by the body. In pharmaceutics, however, “bioequivalent” has a precise and different meaning. It describes two medicines with the same active ingredient that, once taken, release the same amount of substance into the body over the same time, as happens between a brand-name drug and its generic equivalent. This is why, when talking to your doctor or reading a package leaflet, the correct term for a hormone identical to the human one remains “bioidentical”.
Bioidentical hormones: which ones are there and what are they used for in menopause?

Now that it is clear what “bioidentical” means and why this name is used, let’s look at the bioidentical hormones used in menopause. There aren’t many, and each one has a different role: some help reduce hot flashes and night sweats, others relieve vaginal dryness, and others still protect the uterus during estrogen therapy.
Among the most common:
- estradiol: the main estrogen produced by the ovaries, used for hot flashes, night sweats and bone health;
- micronized progesterone: which is combined with estradiol in women who have a uterus, to protect it;
- vaginal estriol and estradiol: at low doses, for dryness, burning and intimate discomfort.
In the following sections we look at them one by one: how they work, when they can be helpful and what precautions they require.
1. Estradiol: for hot flashes, night sweats and bone health
17β-estradiol is one of the main estrogens of the reproductive years. In systemic HRT it can be taken by mouth or through the skin, depending on the formulations available. Systemic estrogens are the most effective treatment for hot flashes and night sweats. It can improve the quality of sleep, especially when sleep problems are linked to vasomotor symptoms, and it helps prevent bone loss and reduce the risk of fractures during treatment.
The route of administration affects the safety profile: oral estrogens increase the risk of venous thromboembolism, while transdermal estrogens, at commonly used doses, do not appear to be associated with a significant increase in that risk. The comparative evidence comes mainly from observational studies.
2. Micronized progesterone: to protect the endometrium
When it comes to progesterone in menopause, its main job is to protect the uterus. If you are on systemic estrogen therapy, that is, taken by mouth or through the skin, a progestogen usually needs to be added as well. Estrogens, in fact, stimulate the growth of the endometrium, the layer that lines the inside of the uterus: without a balancing action, this tissue could thicken (hyperplasia) and, over time, the likelihood of developing endometrial cancer would increase. The progestogen provides exactly this balancing function.
Micronized progesterone is a bioidentical progesterone, meaning it has the same structure as the progesterone produced by the ovaries. “Micronized” means the substance is reduced to very fine particles, so that the body can absorb it better. Some formulations can cause drowsiness, which is why they are often taken in the evening.
Compared with other progestogens, some observational studies suggest that micronized progesterone may have a more favorable risk profile. These data, however, do not show that it eliminates the breast risk: this is something to assess together with your specialist, in light of your personal and family history.
Dose and duration are set according to the amount of estrogen being taken and the chosen treatment regimen. In some cases progesterone is taken every day, in others for about 12 days a month, cyclically. After a total hysterectomy, that is, removal of the uterus, this protection is usually no longer needed, except in particular situations assessed by your doctor.
3. Estriol and vaginal estrogens: local treatment is different
Vaginal dryness, burning, pain during sex and some urinary symptoms can be part of the genitourinary syndrome of menopause. Low-dose vaginal estrogens, including estriol and estradiol, act mainly at a local level.
This is an important distinction: they are not equivalent to systemic HRT. With low-dose vaginal estrogen formulations, used according to their licensed indications, adding a progestogen for endometrial protection is generally not necessary. Any postmenopausal vaginal bleeding nevertheless requires a clinical assessment. Vaginal prasterone (DHEA) can also be an option for specific indications; it is, however, a distinct treatment, not simply another name for estriol.
Bioidentical hormones and HRT: what is the difference?
It is one of the most frequent questions, and the answer may surprise you: bioidentical hormones and HRT are not two alternative paths to choose between. The two expressions describe different things. Hormone replacement therapy in menopause refers to the treatment, that is, the use of hormones to ease the symptoms linked to their decline; “bioidentical”, on the other hand, describes a characteristic of the molecule used, namely the fact that it has the same structure as a hormone produced by the body.
HRT, therefore, may or may not be bioidentical. It can contain estradiol and micronized progesterone, which are bioidentical hormones, or other molecules, such as some synthetic progestogens, whose structure is similar but not identical to that of the progesterone produced by the ovaries. In both cases these are licensed medicines, subject to the same checks on quality, efficacy and tolerability.
The difference between bioidentical and synthetic hormones should also be read with awareness. The fact that a molecule is bioidentical does not, on its own, mean that it is more effective or more suitable than another. The choice between the different options depends on your symptoms, your medical history, whether you have a uterus, the most appropriate route of administration and your personal preferences, and it is an assessment to build together with a gynecologist experienced in menopause.
Benefits, contraindications and choosing HRT: what to consider
For many healthy women with significant symptoms who start systemic HRT before the age of 60 or within ten years of their last period, the balance between benefits and risks is generally favorable, in the absence of contraindications. This is a clinical guideline, not an automatic rule.
Current or past breast cancer, undiagnosed genital bleeding, active liver disease or significant thromboembolic and cardiovascular conditions require a specific assessment of the contraindications to systemic HRT. Thromboembolic risk must be distinguished according to the route of estrogen administration, since transdermal therapy has a different risk profile from oral therapy.
Local low-dose vaginal treatments have different characteristics and should be assessed separately. HRT is not prescribed as a general strategy to prevent heart attack or dementia.
In perimenopause a therapy can be considered even before your last period, but remember: HRT is not a contraceptive. If pregnancy is still possible and not wanted, contraception also needs to be discussed.
Who prescribes bioidentical hormones and where can you get them?
Bioidentical hormones, like all hormone therapies, are prescribed by a doctor. The specialists to turn to are a gynecologist or an endocrinologist, ideally with specific experience in menopause, because the choice takes many aspects into account at once: your symptoms, the stage you are going through, and your personal and family history.
The process usually begins with an in-depth consultation, in which the specialist gathers information about your health, the medicines you take and your family history, and listens to which symptoms affect your daily life the most. Based on this picture, she may suggest some tests, when she considers them useful to complete the assessment. Once started, hormone therapy is reviewed over time, with a first check-up after a few months and then regular follow-ups.
Once you have the prescription, bioidentical hormones are medicines and are bought at the pharmacy, with a doctor’s prescription. They are not supplements or over-the-counter products, and products sold online without a prescription or presented as “natural hormones” in herbal shops do not fall into this category. At the pharmacy they can come in two different forms: as licensed, industrially manufactured medicines, ready-made and in standard doses, or as compounded preparations.
Licensed medicines and compounded preparations: clearing things up without prejudice
When looking for information on bioidentical hormones, you will often come across “tailor-made” therapies, prepared specifically in the pharmacy for a single woman. These are the so-called compounded bioidentical hormones: personalized blends, sometimes offered as a more natural alternative to conventional medicines. To find your way, it helps to understand how they differ from licensed medicines.
A compounded preparation is not an improvised product: it is made up by the pharmacist, according to specific regulations, on a doctor’s prescription when required. It can meet individual needs that a formulation available on the market does not, for example a particular formulation requirement.
The point is not to label compounded preparations as “good” or “bad”. The point is to understand what evidence is available for each product. Licensed, industrially manufactured medicines go through an assessment of quality, efficacy and safety, with established dose and control characteristics. A personalized hormone blend does not go through the same authorization process as an individual industrially manufactured medicine and often lacks solid studies on the specific formulation.
The main scientific societies, including IMS and ACOG, advise against the routine use of compounded bioidentical hormone preparations, because of the lack of adequate evidence on the efficacy and safety of the specific formulations and because of the different standards of control and regulation compared with licensed medicines. Where available, licensed medicines that meet the patient’s clinical needs should be preferred. This is not a condemnation of compounding in general: it is a recommendation based on the level of evidence and on the ability to monitor the quality of the treatment.
In general, a responsible choice also considers accessibility, indication, clinical experience and the woman’s needs, not just the product label.
Three different things not to confuse
- HRT with licensed bioidentical hormones: for example, medicines based on estradiol or micronized progesterone.
- Licensed HRT with other molecules: medicines subject to the same regulatory system, but with substances that are not necessarily bioidentical.
- Compounded bioidentical preparations: made up in the pharmacy for a specific person; the molecule may be the same, but the evidence on the blend and the regulatory pathway are different.
Can saliva tests be used to personalize the dose?
The idea of getting an exact dose from a simple test is appealing, but scientific societies do not recommend salivary hormone tests for setting up personalized bioidentical preparations. Nor does a single blood test, used indiscriminately, make it possible to find the ideal dose of HRT. Hormone measurements can play a role in specific conditions: they should not, however, be mistaken for a universal shortcut. Symptoms, medical history, individual risk and response to treatment remain central.
What about testosterone? What the evidence says
Women produce testosterone too, but there is no universal “crash” in this hormone with natural menopause. And a low blood level is not enough, on its own, to diagnose a problem with sexual desire.
The only indication for testosterone treatment supported by solid clinical evidence is hypoactive sexual desire disorder (HSDD) in postmenopausal women, characterized by a persistent reduction in sexual desire associated with clinically significant personal distress. The diagnosis requires a biopsychosocial assessment that also considers relational, psychological, medical and pharmacological factors. In postmenopausal women diagnosed with HSDD, transdermal testosterone treatment may be considered, at doses that keep circulating levels within the female premenopausal physiological range, with clinical and biochemical monitoring. In Italy, since there are no formulations specifically licensed for women, this use is off-label. The average benefit is moderate and not guaranteed for everyone.
There is, however, not enough evidence to recommend testosterone as a general treatment for fatigue, brain fog, weight gain, muscle mass or “anti-aging”. Excessive doses can cause acne and other androgenic effects; long-term safety data remain limited. To learn more about indications, formulations, risks and monitoring, read our dedicated guide to testosterone in menopause.
Talking to a specialist about HRT: what to ask and what to expect?
Precisely because bioidentical hormones, like any hormone therapy, must be prescribed and followed up by a specialist, the first step is knowing when to seek advice. You don’t need to wait until your symptoms become particularly intense or hard to manage. If hot flashes, sleep problems, vaginal dryness or mood changes are starting to affect your quality of life, you can turn to a gynecologist experienced in menopause to assess the possible solutions.
A specialist consultation is also important if you are already using a hormone preparation without regular check-ups, or if you have a family history that makes you unsure about the safety or suitability of certain treatments.
At Pausetiv we believe in an approach that combines scientific expertise with listening to the person. Our specialists focus on perimenopause and menopause and work according to a multidisciplinary model validated by a scientific committee. The goal is to help you understand the different treatment options and identify, together with your specialist, the one best suited to your situation, with reliable information and without judgment.
Start your journey with a Pausetiv specialist
Also, arriving at your appointment with a few questions already in mind can help you clarify doubts and expectations. Rather than focusing only on the definition of “natural hormones”, it is important to understand how the proposed treatment works and why it might be right in your case.
Here are some questions to start from:
- Which symptoms are we treating and what results can we expect?
- Why was this particular molecule and this route of administration chosen?
- What benefits and what risks should I consider based on my medical history?
- If I still have my uterus, what endometrial protection is needed?
- If I am offered a compounded preparation, what specific need is it meant to meet? Is there a licensed product suitable for my case?
- If testosterone is being discussed, what is the indication, what monitoring is planned and what are the limits of the evidence?
- When is the first check-up scheduled and how often will I need to review the therapy?
Monitoring is an integral part of treatment. Generally, a first review is scheduled about three months after starting the therapy or after a change to it. After that, if the clinical picture is stable, regular check-ups are carried out at least once a year.
The Pausetiv view on bioidentical hormones for menopause
When it comes to bioidentical hormones and hormone replacement therapy, it is easy to feel lost among conflicting information, promises of more natural treatments and doubts about possible risks. As we have seen, however, there is no single best therapy, but rather a treatment that may be more or less suitable depending on each woman’s needs and medical history.
This is why, at Pausetiv, we believe the first step is having access to scientifically sound information and to a medical conversation in which you feel free to ask questions, voice doubts and talk about your choices, even when you are already on a therapy. The goal is not to decide for you, but to help you understand the benefits, risks and alternatives available, so you can approach menopause with greater awareness.
If you are considering hormone therapy or want to better understand the options available to you, you can start with a free consultation with the Pausetiv team. It will be an opportunity to share your needs, clear up your first doubts and understand which path might suit you best.
Book a free consultation with the Pausetiv team
Disclaimer: the information in this article is for informational and educational purposes only. It does not replace the opinion, diagnosis or advice of a doctor or healthcare professional. Do not start, stop or change hormone therapies without talking to a qualified professional. If you have doubts or symptoms that concern you, always consult a qualified specialist.
Frequently asked questions
Are bioidentical hormones safer because they are natural?
No: a bioidentical structure and the plant origin of a precursor do not, on their own, prove greater safety. What matters is the actual formulation and the individual clinical profile.
Are compounded preparations advised against in every case?
No. They can play a role when there is a specific need that available medicines do not meet. Scientific societies do, however, advise against their routine use for bioidentical hormone therapy when suitable licensed alternatives exist.
Do bioidentical and bioequivalent mean the same thing?
No. “Bioidentical” refers to the molecular structure of the hormone; “bioequivalent” refers to the pharmacokinetic comparison between medicines.
Do bioidentical hormones make you gain weight?
The evidence does not show that HRT is in itself a major cause of weight gain. Menopause can be accompanied by changes in body composition and fat distribution. Bloating and breast tenderness may appear at the start of therapy.
Can saliva tests be used to personalize the dose?
The idea of getting an exact dose from a simple test is appealing, but scientific societies do not recommend salivary hormone tests for setting up personalized bioidentical preparations. Nor does a single blood test, used indiscriminately, make it possible to find the ideal dose of HRT. Hormone measurements can play a role in specific conditions: they should not, however, be mistaken for a universal shortcut. Symptoms, medical history, individual risk and response to treatment remain central.
Does a low testosterone test result mean I need to take it?
No. There is no threshold value that, on its own, diagnoses HSDD or calls for therapy. Tests can help monitor treatment when it is indicated.
Sources and further reading
- International Menopause Society, Recommendations and key messages on women’s midlife health and menopause (2025), in particular sections 20 (androgens) and 25 (bioidentical preparations): https://doi.org/10.1080/13697137.2025.2585487
- International Menopause Society, White Paper, Menopause and MHT in 2024: https://pubmed.ncbi.nlm.nih.gov/39268862/
- European Menopause and Andropause Society, The essential menopause curriculum for healthcare professionals (2022): https://pubmed.ncbi.nlm.nih.gov/35115178/
- British Menopause Society, Bioidentical HRT: https://thebms.org.uk/publications/consensus-statements/bioidentical-hrt/
- American College of Obstetricians and Gynecologists, Compounded Bioidentical Menopausal Hormone Therapy (2023): https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2023/11/compounded-bioidentical-menopausal-hormone-therapy
- ISSWSH, Clinical Practice Guideline for the Use of Systemic Testosterone for HSDD in Women (2021): https://pubmed.ncbi.nlm.nih.gov/33792440/
- NICE, Menopause: identification and management: https://www.nice.org.uk/guidance/ng23